|Slideshows|July 22, 2015

6 Ways Neurology Practices Can Get Up-to-Speed with ICD-10

Neurologists will need to improve documentation for several common diagnoses to make a successful ICD-10 transition. Here are six helpful tips.

As with many specialties, neurology will see a variety of changes in ICD-10. Many of these changes do require additional documentation specificity, and neurologists must understand the changes. One goal of ICD-10 is to provide more detailed information for clinical research and treatment purposes. Having accurate data is paramount. Consider the following ways in which neurology practices can prepare for this monumental transition:

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!

Latest CME

In-Person + Virtual Event

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

February 6, 2026

6 Ways Neurology Practices Can Get Up-to-Speed with ICD-10

Newsletter

Related Content

Enhancing Biomarker Use and Targeted Treatment Approaches in Alzheimer Disease: Aaron Burstein, PharmD

Shifting Alzheimer Detection Upstream Using Digital Cognitive Assessments: John Showalter, MD, MSIS

EP. 4 Understanding Depressive Symptom Assessment in Youth with Epilepsy

Advancing Alzheimer Diagnosis and Treatment Through Mechanism-Based Approaches: Takeshi Iwatsubo, MD, PhD

This Week on NeurologyLive® — January 19, 2026

Latest CME

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Putting the Patient First in Acute Pain Management: The PA’s Guide to Incorporating Cutting-Edge Science Into Their Treatment Strategies

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome

FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy

Enhancing Biomarker Use and Targeted Treatment Approaches in Alzheimer Disease: Aaron Burstein, PharmD

Early Opicapone Initiation in Parkinson Leads to Continued Long-Term Therapeutic Benefits

What the EC Decision on High-Dose Spinraza Means for SMA Care